Editorial: The role of circular RNAs and MicroRNAs in non-small cell lung cancer: from mechanisms to therapeutic potential - Top-Institutions - MDSpire

Editorial: The role of circular RNAs and MicroRNAs in non-small cell lung cancer: from mechanisms to therapeutic potential

By
Alexandru Tirpe
Paola Campomenosi
Ioana Berindan-Neagoe
May 27, 2026

Frontiers In Oncology

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

#1

International Association for the Study of Lung Cancer (IASLC)

Denver, Colorado
Key Differentiators
- Oncology
#2

Emory University

Atlanta, Georgia
Key Differentiators
- Oncology
#3

University of Sheffield

Sheffield, England
Key Differentiators
- Oncology
#4

Virginia Cancer Institute

Richmond, Virginia
Key Differentiators
- Oncology
#5

BC Cancer

Vancouver, British Columbia
Key Differentiators
- Oncology

Original Source(s)

Frontiers In Oncology

Editorial: The role of circular RNAs and MicroRNAs in non-small cell lung cancer: from mechanisms to therapeutic potential

by Alexandru Tirpe, Paola Campomenosi, Ioana Berindan-Neagoe
May 27, 2026

Related Content

The Medicine Maker

When Insight Meets Urgency in Cell and Gene Therapy

Balancing deep biological insight with the realities of development is now central to progress in advanced medicine

by Ruizhi Wang, Alan J. Dickson
May 27, 2026
7 min

Baptist Health South Florida

New Mammography Screening Guidance: Clinical Considerations for Risk-Based Care

New guidance from the American College of Physicians (ACP) recommends biennial mammography screening for average-risk women ages 50 to 74.

by
May 26, 2026
5 min

The Medicine Maker

This Week’s Biopharma News: ADCs, Biosimilars, and Microbiome Moves

Merck’s TROP2 ADC delivers a phase III win in endometrial cancer, as new golimumab biosimilars and an oral microbiome therapy move forward

May 26, 2026
9 min